Dennis Leung

Dr. Dennis Leung


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JFJoseph A. Ferrar
Joseph A. Ferrar
BSBenjamin D. Sellers
Benjamin D. Sellers
CCConnie Chan
Connie Chan
DLDennis Leung
Dennis Leung

9 January 2017 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
DLDennis Leung
Dennis Leung
YKYash Kapoor
Yash Kapoor
CACandice Alleyne
Candice Alleyne
EWErika Walsh
Erika Walsh
ALAndrew Leithead
Andrew Leithead
TRTimothy Rhodes
Timothy Rhodes

14 October 2021 in The AAPS Journal
Verified
Journal Article
Closed access
PDF file
ELElizabeth S. Levy
Elizabeth S. Levy
JYJesse Yu
Jesse Yu
AEAlberto Estevez
Alberto Estevez
JMJialin Mao
Jialin Mao
LLLiling Liu
Liling Liu
CYChun-Wan Yen
Chun-Wan Yen

19 February 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DLDennis Leung
Dennis Leung
The pharmaceutical industry has been challenged by the increasing number of poorly soluble drug candidates, resulting in significant issues with obtaining sufficient absorption and bioavailability, risk of exposure variability, and difficulties in achieving a safe therapeutic index. Additionally, the rapid and precise dispensing of specific drug dosages is an important aspect that can enable personalized medicines for the patient. Herein, we report on the development of inkjet printing as a method for delivering precise quantities of poorly soluble drug molecules using commercially available equipment. Despite challenges due to low solubility making it difficult to prepare liquid solutions, stable suspensions of drug nanoparticles with the appropriate viscosity were successfully printed and dispensed onto a thin film suitable for delivery. The drug nanoparticles remained intact and could be reconstituted after printing, demonstrating that they remained stable and retained their advantageous particle size. This demonstrates that inkjet printing can be a practical and convenient approach for dispensing poorly soluble drug molecules when formulated as nanosuspensions.

1 September 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
CYChun-Wan Yen
Chun-Wan Yen
RKRobert Kuhn
Robert Kuhn
CHChloe Hu
Chloe Hu
WZWei Zhang
Wei Zhang
PCPo-Chang Chiang
Po-Chang Chiang
DLDennis Leung
Dennis Leung

28 December 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ALAndrew P. Latham
Andrew P. Latham
ELElizabeth S. Levy
Elizabeth S. Levy
BSBenjamin D. Sellers
Benjamin D. Sellers
DLDennis Leung
Dennis Leung
Drug nanosuspensions offer a promising approach to improve bioavailability for poorly soluble drug candidates. Such formulations often necessitate the inclusion of an excipient to stabilize the drug nanoparticles. However, the rationale for the choice of the correct excipient for a given drug candidate remains unclear. To gain molecular insight into formulation design, this work first utilizes a molecular dynamics simulation to computationally investigate drug–excipient interactions for a number of combinations that have been previously studied experimentally. We find that hydrophobic interactions drive excipient adsorption to drug nanoparticles and that the fraction of polar surface area serves as a predictor for experimental measurements of nanosuspension stability. To test these ideas prospectively, we applied our model to an uncharacterized drug compound, GDC-0810. Our simulations predicted that a salt form of GDC-0810 would lead to more stable nanosuspensions than the neutral form; therefore, we tested the stability of salt GDC-0810 nanosuspensions and found that the salt form readily formed nanosuspensions even without the excipient. To avoid computationally expensive simulations in the future, we extended our model by showing that simple, two-dimensional properties of single drug molecules can be used to rationalize nanosuspension designs without simulations. In all, our work demonstrates how computational tools can provide molecular insight into drug–excipient interactions and aid in rational formulation design.